Ubs Asset Management Americas Inc Exact Sciences Corp Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,590,127 shares of EXAS stock, worth $107 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,590,127
Previous 1,909,413
16.72%
Holding current value
$107 Million
Previous $101 Million
14.26%
% of portfolio
0.02%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
164MCall Options Held
2.2MPut Options Held
1.69M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.19 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.1MShares$1.08 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$809 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.33MShares$357 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...